Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2018 Sep 17;13(9):e0204245.
doi: 10.1371/journal.pone.0204245. eCollection 2018.

Cost-effectiveness of a combination strategy to enhance the HIV care continuum in Swaziland: Link4Health

Affiliations
Randomized Controlled Trial

Cost-effectiveness of a combination strategy to enhance the HIV care continuum in Swaziland: Link4Health

Elizabeth R Stevens et al. PLoS One. .

Abstract

Introduction: Link4Health, a cluster-RCT, demonstrated the effectiveness of a combination strategy targeting barriers at various HIV continuum steps on linkage to and retention in care; showing effectiveness in achieving linkage to HIV care within 1 month plus retention in care at 12 months after HIV testing for people living with HIV (RR 1.48, 95% CI 1.19-1.96, p = 0.002). In addition to standard of care, Link4Health included: 1) Point-of-care CD4+ count testing; 2) Accelerated ART initiation; 3) Mobile phone appointment reminders; 4) Care and prevention package including commodities and informational materials; and 5) Non-cash financial incentive. Our objective was to evaluate the cost-effectiveness of a scale-up of the Link4Health strategy in Swaziland.

Methods and findings: We incorporated the effects and costs of the Link4Health strategy into a computer simulation of the HIV epidemic in Swaziland, comparing a scenario where the strategy was scaled up to a scenario with no implementation. The simulation combined a deterministic compartmental model of HIV transmission with a stochastic microsimulation of HIV progression calibrated to Swaziland epidemiological data. It incorporated downstream health costs potentially saved and infections potentially prevented by improved linkage and treatment adherence. We assessed the incremental cost-effectiveness ratio of Link4Health compared to standard care from a health sector perspective reported in US$2015, a time horizon of 20 years, and a discount rate of 3% in accordance with WHO guidelines.[1] Our results suggest that scale-up of the Link4Health strategy would reduce new HIV infections over 20 years by 11,059 infections, a 7% reduction from the projected 169,019 cases and prevent 5,313 deaths, an 11% reduction from the projected 49,582 deaths. Link4Health resulted in an incremental cost per infection prevented of $13,310 and an incremental cost per QALY gained of $3,560/QALY from the health sector perspective.

Conclusions: Using a threshold of <3 x per capita GDP, the Link4Health strategy is likely to be a cost-effective strategy for responding to the HIV epidemic in Swaziland.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1
Calibration (A) Number of persons living with HIV, (B) Number of HIV Deaths. A. NOTE: The singular point represents the prevalence found in the 2011 population survey. High and low estimates are from UNAIDS. B.NOTE: High and low estimates are from UNAIDS.
Fig 2
Fig 2. Link4Health impact on model pathways.
Fig 3
Fig 3
Undiscounted change in (A) HIV Prevalence, (B) Number of new infections, (C) Number of HIV-related Deaths, and (D) Undiscounted cost and undiscounted QALYs gained.
Fig 4
Fig 4. Discounted cost-effectiveness sensitivity analysis.

References

    1. Walker DG, Hutubessy R, Beutels P. WHO Guide for standardisation of economic evaluations of immunization programmes. Vaccine. 2010;28(11):2356–9. 10.1016/j.vaccine.2009.06.035 - DOI - PubMed
    1. Bicego GT, Nkambule R, Peterson I, Reed J, Donnell D, Ginindza H, et al. Recent patterns in population-based HIV prevalence in Swaziland. PLoS One. 2013;8(10):e77101 Epub 2013/10/22. 10.1371/journal.pone.0077101 ; PubMed Central PMCID: PMCPMC3797108. - DOI - PMC - PubMed
    1. Justman J, Reed JB, Bicego G, Donnell D, Li K, Bock N, et al. Swaziland HIV Incidence Measurement Survey (SHIMS): a prospective national cohort study. The Lancet HIV. 10.1016/S2352-3018(16)30190-4. - DOI - PMC - PubMed
    1. Centers for Disease Control. CDC in Swaziland: Factsheet 2013 [january 12, 2017]. Available from: https://www.cdc.gov/globalhealth/countries/swaziland/pdf/swaziland_2013.pdf.
    1. Kingdom of Swaziland Ministry of Health. Annual HIV Programs Report, 2015. In: Monitoring & Evaluation Unit: Strategic Information Department, editor. 2015.

Publication types

Substances